FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

414289007: Formoterol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2531468013 Formoterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2534998012 Formoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537703011 Eformoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3266141000005111 formoterol da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Formoterol (substance) Is a Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) true Inferred relationship Some
Formoterol (substance) Is a respiratorisk sympatomimetikon false Inferred relationship Some
Formoterol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta adrenergic receptor agonist (disposition) false Inferred relationship Some
Formoterol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta-2 adrenergic receptor agonist true Inferred relationship Some
Formoterol (substance) Is a Ethanolamine and/or ethanolamine derivative (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Formoterol fumarate Is a False Formoterol (substance) Inferred relationship Some
Product containing budesonide and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
budesonid 80 µg + formoterol 4,5 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
budesonid 160 µg + formoterol 4,5 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
budesonid 320 µg + formoterol 9 µg tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
Product containing formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Budesonide+eformoterol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
budesonid 200 µg + formoterolfumarat 6 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
budesonid+eformoterolfumarat 100/6 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
budesonid 400 µg + formoterolfumarat-dihydrat 12 µg indåndingsudløst tørpulverinhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
formoterol 20 µg, inhalationsvæske, opløsning, hætteglas a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
Product containing formoterol and mometasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Product containing formoterol and glycopyrronium bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
Product containing formoterol and glycopyrronium bromide in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol (substance) Inferred relationship Some
Formoterol fumarate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Formoterol (substance) Inferred relationship Some
Product containing formoterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Budesonide and formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Product containing only formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Product containing only formoterol and mometasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Budesonide and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Formoterol (substance) Inferred relationship Some 2
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Formoterol (substance) Inferred relationship Some 2
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Formoterol (substance) Inferred relationship Some 2
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Formoterol (substance) Inferred relationship Some 2
Product containing aclidinium and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Product containing only aclidinium and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Aclidinium- and formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Aclidinium and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 1
Product containing only formoterol and tiotropium in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Formoterol and tiotropium only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Formoterol- and tiotropium-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Formoterol- and tiotropium-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Ciclesonide- and formoterol- and tiotropium-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Product containing only ciclesonide and formoterol and tiotropium in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Product containing only ciclesonide and formoterol and tiotropium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Fluticasone and formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Fluticasone- and formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Fluticasone- and formoterol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2
Fluticasone and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start